相关实验视频

Updated: May 5, 2026

Thermal Ablation for the Treatment of Abdominal Tumors

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

多焦点 papillary 甲状腺微癌的热切除术:一个系统的审查和元分析

Junping Zhang¹, Jiarong Liu¹, Wanting Yi¹

¹Department of Endocrine and Metabolism, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.

|February 6, 2024

概括

热移除 (TA) 有效地治疗多焦点 papillary 甲状腺微癌 (MPTMC),显示92.8%的瘤完全消失率与低并发症率. 专业知识和严格的标准是MPTMC管理中最佳结果的关键.

科学领域:

内分泌学在内分泌学.
在瘤学瘤学.
最少侵入性的手术

背景情况:

多焦点 papillary 甲状腺微瘤 (MPTMC) 提出了治疗挑战.
现有的临床研究表明热除 (TA) 是MPTMC的潜在安全和有效选择.
以前缺乏对TA在MPTMC管理中的有效性进行全面的系统评估.

研究的目的:

系统地评估热切除菌 (TA) 在管理多焦点乳头甲状腺微癌 (MPTMC) 的有效性.

主要方法:

在PubMed,EMBASE和Cochrane图书馆数据库中进行系统的文献搜索,直到2023年10月23日.
数据提取和质量评估由两个独立审查员根据PRISMA指南进行.
来自四项已识别的研究的数据的元分析.

主要成果:

对169名患者389个瘤的分析显示,MPTMC完全消失率为92.8%.
整体并发症率为4.4%,局部复发率低 (0.2%) 和淋巴结转移率低 (1.2%).
没有观察到远程转移或延迟的手术;6名患者出现了新的PTMC.

结论:

热除是MPTMC中局部瘤控制的可行和有效方法.
治疗TA的成功结果取决于严格的患者选择和高水平的程序专业知识.

关键词:

多焦点瘤是一个多焦点瘤.乳头甲状腺小癌的小细胞甲状腺小癌.系统性审查系统性审查热性消去是热性消去的一种.

更多相关视频

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

相关概念视频

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...